"Antifibrinolytic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders.
Descriptor ID |
D000933
|
MeSH Number(s) |
D27.505.519.421.500 D27.505.954.502.270.463.091
|
Concept/Terms |
Plasmin Inhibitors- Plasmin Inhibitors
- Inhibitors, Plasmin
- Antiplasmins
- Plasmin Inhibitor
- Inhibitor, Plasmin
|
Below are MeSH descriptors whose meaning is more general than "Antifibrinolytic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antifibrinolytic Agents".
This graph shows the total number of publications written about "Antifibrinolytic Agents" by people in this website by year, and whether "Antifibrinolytic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
2002 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2012 | 0 | 2 | 2 |
2013 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antifibrinolytic Agents" by people in Profiles.
-
Tilvawala R, Nemmara VV, Reyes AC, Sorvillo N, Salinger AJ, Cherpokova D, Fukui S, Gutch S, Wagner D, Thompson PR. The role of SERPIN citrullination in thrombosis. Cell Chem Biol. 2021 12 16; 28(12):1728-1739.e5.
-
Holley SL, Green K, Mills M, Detterman C, Rappold MF, Thayer S. Educating Parents on Vitamin K Prophylaxis for Newborns. Nurs Womens Health. 2020 Aug; 24(4):283-293.
-
Ayers DC. Tranexamic Acid: Both Efficacious and Safe When Used in Total Hip Arthroplasty to Reduce Blood Transfusions: Commentary on an article by Alexander Dastrup, MD, et al.: "Perioperative Tranexamic Acid Treatment and Risk of Cardiovascular Events or Death After Total Hip Arthroplasty. A Population-Based Cohort Study from National Danish Databases". J Bone Joint Surg Am. 2018 10 17; 100(20):e135.
-
Howard JT, Stockinger ZT, Cap AP, Bailey JA, Gross KR. Military use of tranexamic acid in combat trauma: Does it matter? J Trauma Acute Care Surg. 2017 10; 83(4):579-588.
-
Mitra B, Mazur S, Cameron PA, Bernard S, Burns B, Smith A, Rashford S, Fitzgerald M, Smith K, Gruen RL. Tranexamic acid for trauma: filling the 'GAP' in evidence. Emerg Med Australas. 2014 Apr; 26(2):194-7.
-
Matteson KA, Rahn DD, Wheeler TL, Casiano E, Siddiqui NY, Harvie HS, Mamik MM, Balk EM, Sung VW. Nonsurgical management of heavy menstrual bleeding: a systematic review. Obstet Gynecol. 2013 Mar; 121(3):632-643.
-
Loke C, Ali SS, Johari V. Pharmacology of anticoagulants. Dis Mon. 2012 Aug; 58(8):424-30.
-
Schnatz PF, Marakovits KA, O'Sullivan DM, Ethun K, Clarkson TB, Appt SE. Response to an adequate dietary intake of vitamin D3 modulates the effect of estrogen therapy on bone density. J Womens Health (Larchmt). 2012 Aug; 21(8):858-64.
-
Raghunathan K, Connelly NR, Kanter GJ. e-Aminocaproic acid and clinical value in cardiac anesthesia. J Cardiothorac Vasc Anesth. 2011 Feb; 25(1):16-9.
-
Mitra B, Fitzgerald M, Cameron PA, Gruen RL. Tranexamic acid for trauma. Lancet. 2010 Sep 25; 376(9746):1049; author reply 1050-1.